Bertoletti A, Le Bert N, Tan AT, Boni C, et al. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB, by Huang et al. J Hepatology 77, 42-54 (2022). J Hepatol 2023 Jun 10:S0168-8278(23)00408-7. doi: 10.1016/j.jhep.2023.
PMID: 37307998